International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations

Standard

International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations : Results of the MAC (Montalcino Aortic Consortium). / Jondeau, Guillaume; Ropers, Jacques; Regalado, Ellen; Braverman, Alan; Evangelista, Arturo; Teixedo, Guisela; De Backer, Julie; Muiño-Mosquera, Laura; Naudion, Sophie; Zordan, Cecile; Morisaki, Takayuki; Morisaki, Hiroto; Von Kodolitsch, Yskert; Dupuis-Girod, Sophie; Morris, Shaine A; Jeremy, Richmond; Odent, Sylvie; Adès, Leslie C; Bakshi, Madhura; Holman, Katherine; LeMaire, Scott; Milleron, Olivier; Langeois, Maud; Spentchian, Myrtille; Aubart, Melodie; Boileau, Catherine; Pyeritz, Reed; Milewicz, Dianna M; Montalcino Aortic Consortium.

In: CIRC-CARDIOVASC GENE, Vol. 9, No. 6, 12.2016, p. 548-558.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Jondeau, G, Ropers, J, Regalado, E, Braverman, A, Evangelista, A, Teixedo, G, De Backer, J, Muiño-Mosquera, L, Naudion, S, Zordan, C, Morisaki, T, Morisaki, H, Von Kodolitsch, Y, Dupuis-Girod, S, Morris, SA, Jeremy, R, Odent, S, Adès, LC, Bakshi, M, Holman, K, LeMaire, S, Milleron, O, Langeois, M, Spentchian, M, Aubart, M, Boileau, C, Pyeritz, R, Milewicz, DM & Montalcino Aortic Consortium 2016, 'International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the MAC (Montalcino Aortic Consortium)', CIRC-CARDIOVASC GENE, vol. 9, no. 6, pp. 548-558. https://doi.org/10.1161/CIRCGENETICS.116.001485

APA

Jondeau, G., Ropers, J., Regalado, E., Braverman, A., Evangelista, A., Teixedo, G., De Backer, J., Muiño-Mosquera, L., Naudion, S., Zordan, C., Morisaki, T., Morisaki, H., Von Kodolitsch, Y., Dupuis-Girod, S., Morris, S. A., Jeremy, R., Odent, S., Adès, L. C., Bakshi, M., ... Montalcino Aortic Consortium (2016). International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the MAC (Montalcino Aortic Consortium). CIRC-CARDIOVASC GENE, 9(6), 548-558. https://doi.org/10.1161/CIRCGENETICS.116.001485

Vancouver

Bibtex

@article{48e0f17f0aa5484493830cf1d6f1aa73,
title = "International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the MAC (Montalcino Aortic Consortium)",
abstract = "BACKGROUND: The natural history of aortic diseases in patients with TGFBR1 or TGFBR2 mutations reported by different investigators has varied greatly. In particular, the current recommendations for the timing of surgical repair of the aortic root aneurysms may be overly aggressive.METHODS AND RESULTS: The Montalcino Aortic Consortium, which includes 15 centers worldwide that specialize in heritable thoracic aortic diseases, was used to gather data on 441 patients from 228 families, with 176 cases harboring a mutation in TGBR1 and 265 in TGFBR2. Patients harboring a TGFBR1 mutation have similar survival rates (80% survival at 60 years), aortic risk (23% aortic dissection and 18% preventive aortic surgery), and prevalence of extra-aortic features (29% hypertelorism, 53% cervical arterial tortuosity, and 27% wide scars) when compared with patients harboring a TGFBR2 mutation. However, TGFBR1 males had a greater aortic risk than females, whereas TGFBR2 males and females had a similar aortic risk. Additionally, aortic root diameter prior to or at the time of type A aortic dissection tended to be smaller in patients carrying a TGFBR2 mutation and was ≤45 mm in 6 women with TGFBR2 mutations, presenting with marked systemic features and low body surface area. Aortic dissection was observed in 1.6% of pregnancies.CONCLUSIONS: Patients with TGFBR1 or TGFBR2 mutations show the same prevalence of systemic features and the same global survival. Preventive aortic surgery at a diameter of 45 mm, lowered toward 40 in females with low body surface area, TGFBR2 mutation, and severe extra-aortic features may be considered.",
keywords = "Aorta, Thoracic/diagnostic imaging, Aortic Diseases/diagnostic imaging, Australia/epidemiology, Europe/epidemiology, Female, Genetic Predisposition to Disease, Heterozygote, Humans, Japan/epidemiology, Kaplan-Meier Estimate, Male, Mutation, Phenotype, Pregnancy, Pregnancy Complications, Cardiovascular/diagnostic imaging, Prevalence, Proportional Hazards Models, Protein-Serine-Threonine Kinases/genetics, Receptor, Transforming Growth Factor-beta Type I, Receptor, Transforming Growth Factor-beta Type II, Receptors, Transforming Growth Factor beta/genetics, Registries, Retrospective Studies, Risk Factors, Severity of Illness Index, Treatment Outcome, United States/epidemiology, Vascular Surgical Procedures",
author = "Guillaume Jondeau and Jacques Ropers and Ellen Regalado and Alan Braverman and Arturo Evangelista and Guisela Teixedo and {De Backer}, Julie and Laura Mui{\~n}o-Mosquera and Sophie Naudion and Cecile Zordan and Takayuki Morisaki and Hiroto Morisaki and {Von Kodolitsch}, Yskert and Sophie Dupuis-Girod and Morris, {Shaine A} and Richmond Jeremy and Sylvie Odent and Ad{\`e}s, {Leslie C} and Madhura Bakshi and Katherine Holman and Scott LeMaire and Olivier Milleron and Maud Langeois and Myrtille Spentchian and Melodie Aubart and Catherine Boileau and Reed Pyeritz and Milewicz, {Dianna M} and {Montalcino Aortic Consortium}",
note = "{\textcopyright} 2016 American Heart Association, Inc.",
year = "2016",
month = dec,
doi = "10.1161/CIRCGENETICS.116.001485",
language = "English",
volume = "9",
pages = "548--558",
journal = "CIRC-CARDIOVASC GENE",
issn = "1942-325X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations

T2 - Results of the MAC (Montalcino Aortic Consortium)

AU - Jondeau, Guillaume

AU - Ropers, Jacques

AU - Regalado, Ellen

AU - Braverman, Alan

AU - Evangelista, Arturo

AU - Teixedo, Guisela

AU - De Backer, Julie

AU - Muiño-Mosquera, Laura

AU - Naudion, Sophie

AU - Zordan, Cecile

AU - Morisaki, Takayuki

AU - Morisaki, Hiroto

AU - Von Kodolitsch, Yskert

AU - Dupuis-Girod, Sophie

AU - Morris, Shaine A

AU - Jeremy, Richmond

AU - Odent, Sylvie

AU - Adès, Leslie C

AU - Bakshi, Madhura

AU - Holman, Katherine

AU - LeMaire, Scott

AU - Milleron, Olivier

AU - Langeois, Maud

AU - Spentchian, Myrtille

AU - Aubart, Melodie

AU - Boileau, Catherine

AU - Pyeritz, Reed

AU - Milewicz, Dianna M

AU - Montalcino Aortic Consortium

N1 - © 2016 American Heart Association, Inc.

PY - 2016/12

Y1 - 2016/12

N2 - BACKGROUND: The natural history of aortic diseases in patients with TGFBR1 or TGFBR2 mutations reported by different investigators has varied greatly. In particular, the current recommendations for the timing of surgical repair of the aortic root aneurysms may be overly aggressive.METHODS AND RESULTS: The Montalcino Aortic Consortium, which includes 15 centers worldwide that specialize in heritable thoracic aortic diseases, was used to gather data on 441 patients from 228 families, with 176 cases harboring a mutation in TGBR1 and 265 in TGFBR2. Patients harboring a TGFBR1 mutation have similar survival rates (80% survival at 60 years), aortic risk (23% aortic dissection and 18% preventive aortic surgery), and prevalence of extra-aortic features (29% hypertelorism, 53% cervical arterial tortuosity, and 27% wide scars) when compared with patients harboring a TGFBR2 mutation. However, TGFBR1 males had a greater aortic risk than females, whereas TGFBR2 males and females had a similar aortic risk. Additionally, aortic root diameter prior to or at the time of type A aortic dissection tended to be smaller in patients carrying a TGFBR2 mutation and was ≤45 mm in 6 women with TGFBR2 mutations, presenting with marked systemic features and low body surface area. Aortic dissection was observed in 1.6% of pregnancies.CONCLUSIONS: Patients with TGFBR1 or TGFBR2 mutations show the same prevalence of systemic features and the same global survival. Preventive aortic surgery at a diameter of 45 mm, lowered toward 40 in females with low body surface area, TGFBR2 mutation, and severe extra-aortic features may be considered.

AB - BACKGROUND: The natural history of aortic diseases in patients with TGFBR1 or TGFBR2 mutations reported by different investigators has varied greatly. In particular, the current recommendations for the timing of surgical repair of the aortic root aneurysms may be overly aggressive.METHODS AND RESULTS: The Montalcino Aortic Consortium, which includes 15 centers worldwide that specialize in heritable thoracic aortic diseases, was used to gather data on 441 patients from 228 families, with 176 cases harboring a mutation in TGBR1 and 265 in TGFBR2. Patients harboring a TGFBR1 mutation have similar survival rates (80% survival at 60 years), aortic risk (23% aortic dissection and 18% preventive aortic surgery), and prevalence of extra-aortic features (29% hypertelorism, 53% cervical arterial tortuosity, and 27% wide scars) when compared with patients harboring a TGFBR2 mutation. However, TGFBR1 males had a greater aortic risk than females, whereas TGFBR2 males and females had a similar aortic risk. Additionally, aortic root diameter prior to or at the time of type A aortic dissection tended to be smaller in patients carrying a TGFBR2 mutation and was ≤45 mm in 6 women with TGFBR2 mutations, presenting with marked systemic features and low body surface area. Aortic dissection was observed in 1.6% of pregnancies.CONCLUSIONS: Patients with TGFBR1 or TGFBR2 mutations show the same prevalence of systemic features and the same global survival. Preventive aortic surgery at a diameter of 45 mm, lowered toward 40 in females with low body surface area, TGFBR2 mutation, and severe extra-aortic features may be considered.

KW - Aorta, Thoracic/diagnostic imaging

KW - Aortic Diseases/diagnostic imaging

KW - Australia/epidemiology

KW - Europe/epidemiology

KW - Female

KW - Genetic Predisposition to Disease

KW - Heterozygote

KW - Humans

KW - Japan/epidemiology

KW - Kaplan-Meier Estimate

KW - Male

KW - Mutation

KW - Phenotype

KW - Pregnancy

KW - Pregnancy Complications, Cardiovascular/diagnostic imaging

KW - Prevalence

KW - Proportional Hazards Models

KW - Protein-Serine-Threonine Kinases/genetics

KW - Receptor, Transforming Growth Factor-beta Type I

KW - Receptor, Transforming Growth Factor-beta Type II

KW - Receptors, Transforming Growth Factor beta/genetics

KW - Registries

KW - Retrospective Studies

KW - Risk Factors

KW - Severity of Illness Index

KW - Treatment Outcome

KW - United States/epidemiology

KW - Vascular Surgical Procedures

U2 - 10.1161/CIRCGENETICS.116.001485

DO - 10.1161/CIRCGENETICS.116.001485

M3 - SCORING: Journal article

C2 - 27879313

VL - 9

SP - 548

EP - 558

JO - CIRC-CARDIOVASC GENE

JF - CIRC-CARDIOVASC GENE

SN - 1942-325X

IS - 6

ER -